SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 120 filers reported holding SYNAGEVA BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,137,000 | +31.1% | 32,156 | +24.8% | 0.00% | +50.0% |
| Q4 2014 | $2,392,000 | +154.5% | 25,774 | +88.7% | 0.00% | +100.0% |
| Q3 2014 | $940,000 | -51.3% | 13,662 | -25.8% | 0.00% | -50.0% |
| Q2 2014 | $1,931,000 | -4.6% | 18,421 | -24.5% | 0.00% | 0.0% |
| Q1 2014 | $2,024,000 | +87.8% | 24,399 | +46.3% | 0.00% | +100.0% |
| Q4 2013 | $1,078,000 | +117.8% | 16,673 | +113.7% | 0.00% | – |
| Q3 2013 | $495,000 | -60.0% | 7,802 | -73.5% | 0.00% | -100.0% |
| Q2 2013 | $1,236,000 | +31.2% | 29,456 | +71.7% | 0.00% | 0.0% |
| Q1 2013 | $942,000 | – | 17,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,660,432 | $1,137,242,000 | 9.46% |
| BB BIOTECH AG | 1,025,476 | $100,015,000 | 2.98% |
| EMORY UNIVERSITY | 9,854 | $961,000 | 1.82% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,245,542 | $316,538,000 | 1.72% |
| New Leaf Venture Partners, L.L.C. | 24,379 | $2,378,000 | 1.61% |
| Alpha Wave Global, LP | 304,000 | $29,649,000 | 1.46% |
| Opus Point Partners Management, LLC | 17,700 | $1,726,000 | 1.45% |
| SECTORAL ASSET MANAGEMENT INC | 365,684 | $35,665,000 | 1.35% |
| Pier Capital, LLC | 61,028 | $5,952,000 | 0.90% |
| Tekla Capital Management LLC | 198,689 | $19,378,000 | 0.77% |